Related Experiment Video
Updated: Feb 22, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
A retrospective observational study of patients with dilated cardiomyopathy undergoing non-cardiac surgery
Insights
Patients with dilated cardiomyopathy undergoing non-cardiac surgery face significant risks. High surgical risk and existing cardiovascular disease increase adverse cardiac events, while low-risk surgery appears relatively safe.
Area of Science:
- Cardiology
- Cardiac Surgery
- Anesthesiology
Background:
- Dilated cardiomyopathy (DCM) poses challenges for non-cardiac surgery.
- Perioperative cardiac risks in DCM patients are not well-defined.
- Understanding these risks is crucial for patient management.
Purpose of the Study:
- To investigate perioperative cardiac risks in patients with dilated cardiomyopathy undergoing non-cardiac surgery.
- To identify factors associated with adverse cardiac outcomes in this population.
Main Methods:
- Retrospective analysis of 127 patients with DCM undergoing non-cardiac surgery (1999-2013).
- Data collected included demographics, clinical factors, and postoperative outcomes (30-day mortality, major adverse cardiac events).
Main Results:
- 18.1% experienced major adverse cardiac events; 5.5% died within 30 days.
- Increased surgical risk (43.5% adverse outcome in high-risk) and pre-existing cardiovascular disease (26.7% adverse outcome) were associated with adverse outcomes.
- Low-risk surgery showed a lower adverse outcome rate (5.9%).
Conclusions:
- Moderate to high surgical risk is linked to increased complications in DCM patients.
- Low-risk non-cardiac surgery may be relatively safe for patients with dilated cardiomyopathy.
- Further research is needed to identify other potential risk factors.
Abstract:
The perioperative risks and factors associated with adverse cardiac outcomes in patients with dilated cardiomyopathy undergoing non-cardiac surgery are unknown. Interrogation of the Nelson Hospital transthoracic echocardiogram database identified 127 patients with dilated cardiomyopathy who satisfied the study criteria and underwent non-cardiac surgery between June 1999 and July 2013. Demographic and clinical data along with postoperative death within 30 days or a major adverse cardiac event were retrieved and analysed. The mean age was 75.9 years. Seventy-one percent of the patients had severe impairment of left ventricular function and 35% had a severely dilated left ventricle. A major adverse cardiac event occurred in 18.1% of patients and 5.5% of patients died within 30 days of surgery. Increased surgical risk and absence of cerebrovascular disease were associated with adverse outcome (P <0.001, P <0.05, respectively). Forty-three and a half percent (43.5%) of patients undergoing high-risk surgery had an adverse outcome compared to 36.1% and 5.9% for moderate and low-risk surgery, respectively. A major adverse cardiac event was observed in 26.7% of patients with cardiovascular disease compared to 9.8% of patients without cardiovascular disease. We were unable to exclude an influence of other potential risk factors due to the retrospective observational nature of the study. These findings highlight a potential increase in complications with moderate or high surgical risk, whilst are reassuring in demonstrating the relative safety of low-risk surgery in this group of high-risk patients.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

